A research team, led by scientists at the Center for Clinical Pharmacology at Washington University School of Medicine and the University of Health Sciences & Pharmacy in St. Louis, have altered the chemical properties of fentanyl and the way that it binds to opioid receptors on nerve cells. The goal is to improve the drug’s safety profile without eliminating its ability to alleviate pain.
Author: Patrick
Understanding, treating pain, reducing opioid use, aim of $11.7 million grant (Links to an external site)
Researchers at Washington University School of Medicine in St. Louis have received a five-year, $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to identify new ways to treat it.
$33 million to support study comparing anesthetic medications (Links to an external site)
Funded by a $33 million grant from the Patient-Centered Outcomes Research Institute (PCORI), a new study led by Michael Avidan, MBBCh, of Washington University School of Medicine in St. Louis and Sachin Kheterpal, MD, of the University of Michigan, will compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.
Department celebrates CRNA Class of 2020
The Nurse Anesthesia program at the Goldfarb School of Nursing celebrated its Commencement virtually on Saturday, December 19, 2020.
Jonathan Zoller, MD, appointed POD 3 Leader
Dr. Zoller will work closely with the WUDA and BJH Perioperative leadership in supporting clinical staff to promote safety, quality, and efficiency in perioperative care.
Gereau honored for mentorship and training in neuroscience research (Links to an external site)
Robert W. Gereau IV, PhD, has received the Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH).
Boosting immune system a potential treatment strategy for COVID-19 (Links to an external site)
New research suggests that the immune systems of COVID-19 patients can’t do enough to protect them from the virus. Researchers are proposing that boosting the immune system could be a potential treatment strategy.
Pratik Sinha, MBChB, PhD, joins department
In addition to pursuing his research, Dr. Sinha will be working clinically and educating residents and fellows in the Barnes-Jewish Hospital ICUs.
Uchenna Ofoma, MD, appointed Director of the Christian Hospital Intensive Care Unit
In his new role as Director, he will partner with hospital and nursing leadership at Christian Hospital to ensure outstanding clinical care in the intensive care unit.
Simon Haroutounian, PhD, appointed Chief of the Division of Clinical and Translational Research (DoCTR)
Dr. Haroutounian also serves as Associate Professor of Anesthesiology and an Adjunct Assistant Professor of Pharmacy Practice at the St. Louis College of Pharmacy.